Epistem Wins UK Trade and Investment Award

Epistem received the UKTI’s ’Internationalise Your Business’ award at the recent Genesis 2009 biotechnology conference in London. UKTI presents this award to the company which it judges has been most successful in
expanding into new markets. Nominee companies are established companies who have extended their footprint with UKTI assistance, notably through the UKTI Tradeshow Access Programme. Epistem, led by Matthew Walls CEO, was extremely pleased to have been honoured with this award, which reflects the rapid recent expansion of its business, working with larger pharmaceutical companies in new overseas markets building on the successful presence which it has achieved in the UK. Other nominated companies for this award were: BioFocus DPI, Eden Biodesign, Epistem, Neem Biotech, Winscribe Europe. The UKTI Assisted Newcomer of the Year Award for first use of UKTI services for internationalisation, and most successful first export, went to Cambridge Temperature Concepts for their spectacular growth from an investment funded startup to international exporter in the space of a single year. The runners up were Bio Nano Consulting and Crystec Pharma. BioPartner.co.uk managed the selection process for the 2009 UK Trade & Investment Internationalisation Awards,
presented at the Genesis Conference Awards Dinner, 10th December, in London. The awards are designed to recognise companies that are successful in exploiting UKTI services to grow their business internationally -
through expert advice and assistance, commissioned market reports and Tradeshow Access Programme grants.